That is very important, because the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be effective. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (future report review). Now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to create drugs that do what they're designed to do. This was an advancement almost no one saw. However it's going to have profound implications for curing disease. I predict that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be plenty of financial investment chances in this space, too. Shifting subjects It's going to be an excellent year for bitcoin. I'm bullish on it in 2021 (last week). That said, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back maybe significantly prior to going greater - toxic tech 5 tech darlings. I've been covering bitcoin for a long period of time now. Among the first research study reports I ever released was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the discussion was at the time. We were primarily educating readers. But that's not the big concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So think about that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge factor I'm bullish on it this year. jeff brown prediction for 2021. Regards, Jeff Brown, Editor, The Bleeding Edge I have a reward forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I forecast 2021 will be another record year in IPOs. There are so lots of excellent personal business on the brink of hitting the public markets And I have actually been dealing with a brand-new method for you to invest even before these business go public.
This opportunity has been building over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to discover all the details. Go right here to reserve your spot free of charge.
Emma Walsh here, handling editor of the Diary. Regular Diary readers know that tech isn't our usual beat (genetic sequencer stock jeff brown). And when it concerns tech investing, we leave it to the experts. Fortunately, we have numerous such specialists in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing experts we know (jeff brown stock predictions). In fact, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the huge image and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, expert system, and much more. These patterns are experiencing rapid development and producing extraordinary chances for financiers. I desire to make certain all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff brown 2020 predictions. However regardless of what lots of readers might believe, this is a trend that's simply beginning. Although the COVID-19 pandemic disrupted supply chains last year, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (second wave). Losing 2 months of production and sales actually impacts the number of 5G gadgets are offered in the fiscal year. When you think about all of that, selling 250 million systems is amazing. More significantly, the hold-ups brought on by the pandemic created a lots of suppressed demand. And that demand is now going to be pushed into 2021. In fact, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - bleeding edge. Which's not my only 5G prediction When I've spoken about 5G in the past, I have actually described its 3 different phases.
In Phase 2, 5G devices go on sale. 5G phones and other items begin to reach consumers. And in Phase 3, 5G services start to be used (tech stock). That's when we start to see applications working on 5G networks. Believe of things like enormous multiplayer games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase 3 by this summer. This starts something of a virtuous cycle: Many people do not truly care about the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That leads to more 5G apps being developed. In reality, 5G is going to open up a suite of unbelievable applications: self-driving automobiles, the Web of Things, robotic surgical treatment, and more. All of these innovations require 5G. The financial investment chances moving forward will be huge. Stepping far from 5G, the next crucial innovation I visualize in 2021 is CRISPR genetic editing. CRISPR means "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it is among the most interesting advancements in biotechnology. At a high level, CRISPR is a technology that can edit our hereditary makeup as if it were software application.
The program can crash or not operate correctly. CRISPR utilizes a similar concept however with our genetic code. "Typos" in our genome can cause disease. CRISPR can correct these "typos." For many years, CRISPR was mainly a niche innovation that wasn't well comprehended. And during that time, there were actually only three business operating in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing actual results. We're dealing with illness and seeing that this technology simply works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire market is successfully a greenfield opportunity.
There's space for many business to exist in this area. future report review. And there will be more. That's my forecast for CRISPR in 2021. I predict that two or three more genetic modifying companies will hold their IPOs. Sticking to biotechnology, we are seeing amazing things happening at the convergence of biotech and artificial intelligence (AI). Google's AI subsidiary, Deep, Mind, just revealed at the end of 2020 that its latest Alpha, Fold software can accurately forecast the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is necessary since the way a protein in the human body folds determines if a pharmaceutical will be able to bind to that protein and work.
Historically, this has actually been a trial-and-error process. Now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're designed to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not simply one but several drug therapies produced using this technology. This was one of those developments that nearly nobody discovered. But it's going to have extensive implications for treating disease. And, naturally, there will be lots of financial investment chances in this space, too.
It's going to be a good year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be amazed if it pulled back possibly substantially before going higher. I have actually been covering bitcoin for a long period of time now. Among the first research reports I ever published was on bitcoin - jeff brown top stock pick 2021. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my suggestion. However at the time of that initial suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That shows you where the conversation was at the time.
But no one is asking that question anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. jeff brown investment prediction. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big reason I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more reward forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the details is up to date since February 2021, but we could not independently validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down an exact figure at this minute. Brown is best understood for his sage-like ability to pick winning technology stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an excellent viewpoint on the marketplace. He's constantly on the hunt for new opportunities, and he shares a number of his finest choices in the Near Future Report.
That's full marks, but it's not absurdly reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively forecasted a few of the greatest financial occasions of the previous twenty years. Although he doesn't appear to release his choices to the public, the service's success is a direct sign of Brown's stock-picking expertise. No one on Wall Street gets it right whenever, but Jeff Brown's accurate forecasts have made him legions of dedicated followers. That says a lot about his ability. The Near Future Report is published by Brownstone Research study, a prominent monetary research publisher. Brownstone Research uses numerous research study services with a wide array of expertises - jeff brown investment prediction.
The business is likewise connected with Bonner & Partners, another well-respected research study publisher - jeff brown biotech stock. On its site, Brownstone states its objective is to supply retail investors with professional-grade research study: "For too long, the very best financial investment research study has actually not been offered to individual financiers. It has been typically scheduled for investment banks, hedge funds, personal equity, and high-net-worth customers. jeff brown predictions for 2021. The objective of Brownstone Research study is to make that type of proprietary research study offered to any investors aiming to acquire an edge in the marketplaces. The objective is basic to provide unique and profitable investment research discovered no place else." -Brownstone Research study site excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also works as the firm's Chief Investment Expert.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of constant success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a family name throughout the majority of America. If you understand even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. biotech stocks. Everything he touches turns to gold! Jeff is aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big job.
In truth, Brown thinks S.A.V. jeff brown top stock pick 2021. could be "the biggest trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be marrying two advanced innovations: artificial intelligence and electric cars and trucks. Musk hopes the mix will help him develop the first fully-autonomous, self-driving automobiles ever. It's absolutely nothing except the automotive industry's Holy Grail. As you understand, electrical cars and self-driving vehicle stocks have been big this year, however the Wall Street device has actually approved buzz without much tangible result. In spite of an extreme boost in competitors over the past couple of years, Brown still thinks Musk has the best chance of putting it all together.
tech might be the magic string that ties it all together. S.A.V. means Shared Autonomous Vehicle, and it could be the future of transport. Essentially, this technology would enable you to lease your automobile as an autonomous, self-driving taxi when you're not utilizing it. You simply leave the automobile and press a button on an app that informs the cars and truck to "join the fleet." Next thing you understand, you're relaxing on your couch while your cars and truck shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the revenues. It sounds ridiculous, but it might be closed than you think.